It is something that needs to be considered. Someone (I think Kiwi) posted information (maybe even on a different board) that most BO occur right around phase (either before or after -ex MDCO) or right around FDA approval. Now with Amarin we may have had a couple of things that gummed up the works.
I thought there was some kind of rumour of interest 6 months after R-I and there was some speculation that JT wanted too much, but who knows.
Then after FDA label expansion we had the DuDisaster 3 months later, which may have put the kibosh on anything serious. But if through BO or some serendipitous fluctuations of the market the sp gets over 10 I will strongly consider bailing.
Market Data 
Markets 
AI
